Is a complete IMA research report available?

No complete published report is available for ImageneBio, Inc. (IMA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ImageneBio, Inc. (IMA)

NASDAQ: IMA · USD

$5.91

+0.34 (+6.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IMA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	66.7M
Net income (ttm)	-53.9M
EPS (ttm)	-$7.06
Shares out	11.3M
Volume	4,696.519
Price target	$13.0	+120.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -53.9M
EPS (ttm): -$7.06
Market cap: 66.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All IMA indicators

Market & fundamental data

Available fields

171

Groups with data

Currency

USD

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001835579
Company name	ImageneBio, Inc.
Country	United States
Country code	US
Cusip	45175G207
Employees	17
Employees Change	2%
Employees Change Percent	13.33
Enterprise value	$-48.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US45175G2075
Last refreshed	2026-07-31
Market cap	$66.7M
Market cap category	Micro-Cap
Price	$5.91
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2836
Symbol	IMA
Website	https://www.inmagenebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-81.25%
FCF yield	-83.55%
P/B ratio	0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-53.9M
Net Income Growth Years	0%
Profit Per Employee	$-3.2M
ROA	-45.61
ROCE	-43
ROE	-86.15
ROIC	-53.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-61.14%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-77.14x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$136.7M
Cash	$117.2M
Current Assets	$122M
Current Liabilities	$6.6M
Debt	$2.4M
Debt Equity	$0.02
Equity	$123.3M
Liabilities	$13.4M
Long Term Assets	$14.7M
Long Term Liabilities	$6.7M
Net Cash	$114.8M
Net Cash By Market Cap	$173
Net Debt Equity	$-0.93
Tangible Book Value	$123.3M
Tangible Book Value Per Share	$10.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.39
Net Working Capital	$470,000
Quick ratio	17.67
Working Capital	$115.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	98.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-61.12%
200-day SMA	6.38
50-day SMA	5.75
50-day SMA vs 200-day SMA	50under200
All Time High	18
All Time High Change	-67.17%
All Time High Date	2025-07-28
All Time Low	3.94
All Time Low Change	50%
All Time Low Date	2026-03-27
ATR	0.32
Beta1y	1.38
Ch YTD	-14.35
High	5.92
High52	17.96
High52 Date	2025-07-31
High52ch	-67.09%
Low	5.57
Low52	3.94
Low52 Date	2026-03-27
Low52ch	50%
Ma50ch	2.75%
Price vs 200-day SMA	-7.31%
RSI	50.26
RSI Monthly	0
RSI Weekly	40.6
Sharpe ratio	-0.98x
Sortino ratio	-1.24
Total Return	98.35%
Tr YTD	-14.35
Tr1m	-2.64%
Tr1w	6.1%
Tr3m	-0.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$13
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.96
Operating Income	$-54.5M
Price target	$13
Price Target Change	$120
Price Target Change Top	$120

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,558,873%
Float Percent	49.28%
Net Borrowing	15,000,000
Shares Insiders	3.74%
Shares Institutions	25.36%
Shares Out	11,279,130
Shares Qo Q	0.26%
Shares Yo Y	-98.35%
Short Float	7.08%
Short Ratio	37.68
Short Shares	3.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-71.6M
Adjusted OCF	-71,624,000
Average Volume	10,343.8x
Bv Per Share	10.93
Ch1m	-2.64
Ch1w	6.1
Ch1y	-61.12
Ch3m	-0.34
Ch6m	-19.32
Change	6.1%
Change From Open	5.54
Close	5.57
Days Gap	0.54
Depreciation Amortization	496,750
Dollar Volume	27,756.4
Earnings Date	2026-08-15
Earnings Time	bmo
EBIT	$-55.9M
EBITDA	$-55.9M
EPS	$-7.06
F Score	1
FCF	$-55.4M
FCF EV Yield	114.32x
FCF Per Share	$-4.91
Financing CF	132,197,000
Fiscal Year End	December
Founded	2,019
Income Tax	$-340,000
Investing CF	-6,254,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	6.04
Ma150ch	-2.14%
Ma20	5.81
Ma20ch	1.74%
Net CF	71,130,000
Next Earnings Date	2026-08-15
Open	5.6
Optionable	No
Position In Range	97.14
Post Close	5.91
Postmarket Change Percent	-2.2
Postmarket Price	$5.78
Ppne	616,000
Price Date	2026-07-30
Ptbv Ratio	0.54
Relative Volume	0.45x
Share Based Comp	16,210,000
Tr6m	-19.32%
Us State	California
Volume	4,696.5
Z Score	1.43

ImageneBio, Inc. (IMA)

Coverage state: Market snapshot only — no published research

Generate the first IMA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · IMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IMA

Frequently asked questions